Matthew M. Poppe
( out of 38 reviews )

Matthew M. Poppe, MD, FASTRO

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

  • Matthew Poppe, MD, a Huntsman Cancer Institute (HCI) physician and investigator, is a professor in the Department of Radiation Oncology at the University of Utah. He is a member of the multidisciplinary pediatric, sarcoma, and breast teams and is director of the residency program in Radiation Oncology.

    As the primary radiation oncologist providing radiation for kids with cancer, he is actively engaged in Children’s Oncology Group and conducts translational, clinical, and outcomes research. He works with the COG in the design of new pediatric clinical trials and is currently the radiation co-chair of AALL 1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy.

    Dr. Poppe is actively engaged in the research and the care of patients with breast cancer. He currently serves as co-chair of the Breast Local Control group and Vice Chair for the Breast Committee for the Alliance Cooperative Trials Group and is a member of the NCI BOLD Task Force for the Breast Cancer Steering Committee. He is the principal investigator on an international trial (RT CHARM/Alliance A221505), which is a phase III randomized trial evaluating the safety and efficacy of short course radiation in the setting of mastectomy with breast reconstruction. He is also the principal investigator of a phase II trial at Huntsman Cancer Institute, evaluating a novel 9-day hypofractionated course of whole breast radiation. Additionally, he has published 34 peer-reviewed manuscripts, 3 book chapters, and presented numerous posters at national and international meetings. In 2018, he was recognized as a Huntsman Translational Scholar.

    Dr. Poppe earned a bachelor’s degree in mechanical engineering at Santa Clara University, Santa Clara, CA. He worked in engineering at NASA AMES before attending medical school at Oregon Health Sciences University, Portland, OR. Dr. Poppe completed a Family Practice residency through the University of California Davis, Mercy Medical Center, Redding, California. In 2001, Dr. Poppe entered active duty in the US Air Force and practiced family and aerospace medicine until 2006. Dr. Poppe completed his radiation oncology residency at the Rutgers Cancer Institute of New Jersey. During residency, he was active in residency training issues as a review committee member for the Accreditation Council for Graduate Medical Education and Executive member of the Association of Residents in Radiation Oncology.

    Specialties

    Patient Rating

    4.9 /5
    ( out of 38 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    HUNTSMAN CANCER CENTER

    Dr. Poppe is an excellent doctor. As a patient I feel taken care of! I feel so grateful to have a skilled and personal doctor I can totally trust!

    HUNTSMAN CANCER CENTER

    Dr. Poppe is so smart and know about his practice. I highly recommend him and completely trust that he will make the best decisions for my treatment.

    HUNTSMAN CANCER CENTER

    Dr. Poppe was kind and explained my situation and what I should expect moving forward with my care.

    HUNTSMAN CANCER CENTER

    I had to fight my insurance company to be able to continue with Dr. Poppe. I did not want to have someone else take over my care plan. He saved my life.

    HUNTSMAN CANCER CENTER

    We love Dr. Poppe. He has taken good care of my son and treats him with dignity and respect.

    SUGAR HOUSE HEALTH CENTER

    Dr. Poppe was caring and listened to my concerns. He answered questions that others should have already answered for me.

    HUNTSMAN CANCER CENTER

    Both Dr. Poppe and his fellow were wonderful. They gave very thorough explanations, were very candid and really put my mind at ease. I felt very comfortable being in their care.

    HUNTSMAN CANCER CENTER

    Dr. Poppe recognized me as an individual, and worked with me as a collaborator regarding my treatment. He earned my trust, and I highly recommend his care.

    HUNTSMAN CANCER CENTER

    Dr Poppe is one the kindest and most understanding Doctors I've had the pleasure of being treated by! He listened to all of my concerns and questions that both me and my husband asked. If I ever need radiation, he will be the one that I go too.

  • Matthew Poppe, MD, a Huntsman Cancer Institute (HCI) physician and investigator, is a professor in the Department of Radiation Oncology at the University of Utah. He is a member of the multidisciplinary pediatric, sarcoma, and breast teams and is director of the residency program in Radiation Oncology.

    As the primary radiation oncologist providing radiation for kids with cancer, he is actively engaged in Children’s Oncology Group and conducts translational, clinical, and outcomes research. He works with the COG in the design of new pediatric clinical trials and is currently the radiation co-chair of AALL 1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy.

    Dr. Poppe is actively engaged in the research and the care of patients with breast cancer. He currently serves as co-chair of the Breast Local Control group and Vice Chair for the Breast Committee for the Alliance Cooperative Trials Group and is a member of the NCI BOLD Task Force for the Breast Cancer Steering Committee. He is the principal investigator on an international trial (RT CHARM/Alliance A221505), which is a phase III randomized trial evaluating the safety and efficacy of short course radiation in the setting of mastectomy with breast reconstruction. He is also the principal investigator of a phase II trial at Huntsman Cancer Institute, evaluating a novel 9-day hypofractionated course of whole breast radiation. Additionally, he has published 34 peer-reviewed manuscripts, 3 book chapters, and presented numerous posters at national and international meetings. In 2018, he was recognized as a Huntsman Translational Scholar.

    Dr. Poppe earned a bachelor’s degree in mechanical engineering at Santa Clara University, Santa Clara, CA. He worked in engineering at NASA AMES before attending medical school at Oregon Health Sciences University, Portland, OR. Dr. Poppe completed a Family Practice residency through the University of California Davis, Mercy Medical Center, Redding, California. In 2001, Dr. Poppe entered active duty in the US Air Force and practiced family and aerospace medicine until 2006. Dr. Poppe completed his radiation oncology residency at the Rutgers Cancer Institute of New Jersey. During residency, he was active in residency training issues as a review committee member for the Accreditation Council for Graduate Medical Education and Executive member of the Association of Residents in Radiation Oncology.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Professor (Clinical)

    Education history

    Undergraduate Mechanical Engineering - Santa Clara University B.S.
    Professional Medical Medicine - Oregon Health Sciences University M.D.
    Residency Family Practice - University of California Davis/Mercy Medical Center Resident
    Residency Radiation Oncology - Robert Wood Johnson Hospital/UMDNJ Resident

    Selected Publications

    Journal Article

    1. Gondi V, Bernard JR Jr, Jabbari S, Keam J, de Amorim Bernstein KL, Dad LK, Li L, Poppe MM, Strauss JB, Chollet CT, ARRO Executive Committee. (2012). Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experience. Am J Clin Oncol, 35(1), 32-9. (Read full publication)
    2. Poppe MM, Narra V, Yue NJ, Zhou J, Nelson C, Jabbour S (2011). A comparison of helical intensity-modulated radiotherapy, intensity-modulated radiotherapy, and 3D-conformal radiation therapy for pancreatic cancer. Medical dosimetry, 36(4), 351-7. (Read full publication)
    3. Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe M (2016). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Medical dosimetry, 41(3), 195-8. (Read full publication)
    4. Lucas CG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S, McDermott M, Berger M, Cham E, Sun PP, Putnam A, Zhou H, Bollo R, Cheshier S, Poppe MM, Fung KM, Sung S, Glenn C, Fan X, Bannykh S, Hu J, Danielpour M, Li R, Alva E, Johnston J, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Tihan T, Bollen AW, Perry A, Solomon DA (2020). Myxoid Glioneuronal Tumor, PDGFRA p.K385-mutant: Clinical, Radiologic, and Histopathologic Features. Brain pathology (Zurich, Switzerland), 30(3), 479-494.
    5. Mazur MD, Ravindra VM, Alashari M, Raetz E, Poppe MM, Bollo R (2015). Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review. Child's nervous system, 31(6), 977-84. (Read full publication)
    6. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney D (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecologic oncology, 141(3), 421-427. (Read full publication)
    7. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney D (2016). Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecologic oncology, 143(3), 690-691. (Read full publication)
    8. Torgeson A, Boothe D, Poppe MM, Suneja G, Gaffney D (2017). Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecologic oncology, 147(2), 320-328. (Read full publication)
    9. Gondi V, Bernard JR Jr, Jabbari S, Keam J, de Amorim Bernstein KL, Dad LK, Li L, Poppe MM, Strauss JB, Chollet CT, ARRO Executive Committee (2011). Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: clinical training and resident working conditions. International journal of radiation oncology, biology, physics, 81(4), 1120-7. (Read full publication)
    10. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe M (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. International journal of radiation oncology, biology, physics, 93(5), 1096-103. (Read full publication)
    11. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe M (2017). Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. International journal of radiation oncology, biology, physics, 97(1), 60-63. (Read full publication)
    12. Bingham B, Orton A, Boothe D, Stoddard G, Huang YJ, Gaffney DK, Poppe M (2017). Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement. International journal of radiation oncology, biology, physics, 97(5), 1040-1050. (Read full publication)
    13. Yovino S, Poppe M, Jabbour S, David V, Garofalo M, Pandya N, Alexander R, Hanna N, Regine W (2011). Intensity-Modulated Radiation Therapy (IMRT) Significantly Improves Acute Gastrointestinal Toxicity in Pancreatic and Ampullary Cancers. International journal of radiation oncology, biology, physics, 79(1), 158-162.
    14. Khan AJ, Chen PY, Yashar C, Poppe MM, Li L, Abou Yehia Z, Vicini FA, Moore D, Dale R, Arthur D, Shah C, Haffty BG, Kuske R (2019). Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. . International journal of radiation oncology, biology, physics, 104(1), 67-74.
    15. Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty B (2017). Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. Journal of clinical oncology, 35(18), 2037-2043. (Read full publication)
    16. Zhao H, Wang B, Rassiah-Szegedi P, Huang Y, Sarkar V, Szegedi M, Sadinski M , Kokeny K, Poppe M, Salter (2011). SU-E-T-527: Comparison of CT-On-Rails and a 3D Surface Imaging System for Image Guided Partial Breast Radiation Therapy. Medical physics, 38(6), 3610.
    17. Badiyan SN, Shah C, Arthur D, Khan AJ, Freedman G, Poppe MM, Vicini F (2014). Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies. Radiotherapy and oncology, 110(1), 39-44. (Read full publication)
    18. Boothe D, Williams N, Odei B, Poppe MM, Werner TL, Suneja G, Gaffney D (2017). The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care. International journal of gynecological cancer, 27(5), 912-922. (Read full publication)
    19. Frandsen J, Cannon G, Kokeny KE, Gaffney DK, Wright M, Pena K, Poppe M (2017). Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review. The breast journal, 23(4), 452-455. (Read full publication)
    20. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe M (2018). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. The breast journal, 24(1), 7-11. (Read full publication)
    21. Frandsen JE, Wagner A, Bollo RJ, Shrieve DC, Poppe M (2015). Long-term life expectancy for children with ependymoma and medulloblastoma. Pediatric blood & cancer, 62(11), 1986-91. (Read full publication)
    22. Francis SR, Frandsen J, Kokeny KE, Gaffney DK, Poppe M (2017). Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers. Breast (Edinburgh, Scotland), 32, 156-161. (Read full publication)
    23. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney D (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast (Edinburgh, Scotland), 35, 122-129. (Read full publication)
    24. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H (2012). Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 10(5), 589-97.
    25. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom (2011). Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network, 9(9), 1020-58.
    26. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H, National comprehensive cancer network (2015). Hodgkin Lymphoma, Version 2.2015. Journal of the National Comprehensive Cancer Network, 13(5), 554-586.
    27. von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Meyer C, Pappo AS, Parkes AM, Paz IB, Petersen IA, Poppe M, Riedel RF, Rubin B, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Bergman MA, George G (2020). NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network, 18(12), 1604-1612.
    28. Tunceroglu A, Park JH, Balasubramanian S, Poppe M, Anker CJ, Poplin E, Moss RA, Yue NJ, Carpizo D, Gannon CJ, Haffty BG, Jabbour S (2012). Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer. ISRN oncology, 2012, 572342.
    29. Burt L, Poppe MM, Kokeny KE, Gaffney DK, Shrieve DC, Tward J (2016). Comparison of treatment modalities for breast cancer arising in Hodgkin's lymphoma survivors. Journal of radiation oncology,
    30. Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt L (2021). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. Journal of neuro-oncology, 151(2), 93-101. (Read full publication)
    31. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer medicine, 9(21), 7954-7963. (Read full publication)
    32. Poppe MM, Yehia ZA, Baker C, Goyal S, Toppmeyer D, Kirstein L, Chen C, Moore DF, Haffty BG, Khan A (2020). 5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial. International journal of radiation oncology, biology, physics, 107(4), 694-700. (Read full publication)
    33. Wells S, Ager B, Hitchcock YJ, Poppe M (2019). The radiation dose-response of non-retroperitoneal soft tissue sarcoma with positive margins: An NCDB analysis. Journal of surgical oncology, 120(8), 1476-1485. (Read full publication)
    34. Boothe D, Orton A, Kim J, Poppe MM, Werner TL, Gaffney D (2019). Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?. American journal of clinical oncology, 42(11), 813-817. (Read full publication)
    35. Ager BJ, Christensen MT, Burt LM, Poppe M (2019). The value of high-dose radiotherapy in intracranial ependymoma. Pediatric blood & cancer, 66(6), e27697. (Read full publication)
    36. Tward JD, Poppe MM, Hitchcock YJ, O'Neil B, Albertson DJ, Shrieve D (2018). Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer medicine, 7(12), 6030-6039. (Read full publication)
    37. Huang YJ, Su FF, Gaffney DK, Kokeny KE, Zhao H, Rassiah-Szegedi P, Salter BJ, Poppe M (2018). Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy, 17(6), 956-965. (Read full publication)
    38. Weiss A, Campbell J, Ballman KV, Sikov WM, Carey LA, Hwang ES, Poppe MM, Partridge AH, Ollila DW, Golshan (2021). Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Annals of surgical oncology, 28(11), 5960-5971. (Read full publication)
    39. Weil CR, Lew FH, Williams VM, Burt LM, Ermoian RP, Poppe M (2022). Patterns of Care and Utilization Disparities in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Advances in radiation oncology, 7(6), 100868. (Read full publication)
    40. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572. (Read full publication)
    41. Peterson JS, Peckham ME, Poppe MM, Burt LS, Shrieve DC, Cannon D (2022). Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Advances in radiation oncology, 7(5), 100994. (Read full publication)
    42. von Mehren M, Kane JM, Riedel RF, Sicklick JK, Pollack SM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Poppe M, Schuetze S, Shabason J, Spraker MB, Zimel M, Bergman MA, Sundar H, Hang L (2022). NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022. Journal of the National Comprehensive Cancer Network, 20(11), 1204-1214. (Read full publication)
    43. Yashar C, Khan AJ, Chen P, Einck J, Poppe M, Li L, Yehia ZA, Vicini FA, Moore D, Arthur D, Quinn TJ, Kowzun M, Simon L, Scanderbeg D, Shah C, Haffty BG, Kuske (2023). Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial. Practical radiation oncology, 13(4), 314-320. (Read full publication)
    44. Zhao H, Sarkar V, St James S, Paxton A, Su FF, Price RG, Dial C, Poppe M, Gaffney D, Salter (2024). Verification of surface-guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT-on-rails and kV-2D alignment. Journal of applied clinical medical physics, 25(2), e14263. (Read full publication)
    45. Berrington de González A, Gibson TM, Lee C, Albert PS, Griffin KT, Kitahara CM, Liu D, Mille MM, Shin J, Bajaj BVM, Flood TE, Gallotto SL, Paganetti H, Ahmed SK, Eaton BR, Indelicato DJ, Milgrom SA, Palmer JD, Baliga S, Poppe MM, Tsang DS, Wong K, Yock T (2023). The Pediatric Proton and Photon Therapy Comparison Cohort: Study Design for a Multicenter Retrospective Cohort to Investigate Subsequent Cancers After Pediatric Radiation Therapy. Advances in radiation oncology, 8(6), 101273. (Read full publication)
    46. Howell J, Maughan B, Fluchel M, Poppe (2024). Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report. Urology case reports, 56, 102799. (Read full publication)
    47. Rose ML, Moen E, Ager B, Bajaj B, Poppe M, Russo G, Yock T (2024). Radiotherapy dosing in intracranial ependymoma using the national cancer database. Journal of neuro-oncology, (Read full publication)
    48. Zhao H, Williams N, Poppe M, Sarkar V, Wang B, Rassiah-Szegedi P, Huang YJ, Kokeny K, Gaffney D, Salter (2019). Comparison of surface guidance and target matching for image-guided accelerated partial breast irradiation (APBI). Medical physics, 46(11), 4717-4724. (Read full publication)
    49. Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney (2016). Brachytherapy improves survival in primary vaginal cancer. Gynecologic oncology, 141(3), 501-506. (Read full publication)
    50. Poppe MM, Tai A, Li XA, Miften M, Olch A, Marks LB, Qureshi BM, Spunt SL, Shnorhavorian M, Nelson G, Ronckers C, Kalapurakal J, Marples B, Constine LS, Liu A (2024). Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International journal of radiation oncology, biology, physics, 119(2), 560-574. (Read full publication)
    51. Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, Coles CE, Gerber NK, Kathpal M, Kim L, Laronga C, Meattini I, Nichols EM, Pierce LJ, Poppe MM, Spears PA, Vinayak S, Whelan T, Lyons J (2024). Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical radiation oncology, 14(2), 112-132. (Read full publication)
    52. Cruttenden J, Grant J, Evans J, Cannon G, Gaffney DK, Poppe M, Burt LM, Avizonis V, Boothe (2025). Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer. American journal of clinical oncology, 48(5), 222-229. (Read full publication)
    53. Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. International journal of radiation oncology, biology, physics, 123(1), 141-149. (Read full publication)
    54. Potter S, Avery K, Ahmed R, de Boniface J, Chatterjee S, Dodwell D, Dubsky P, Federmann J, Finestone S, Gnant M, Hlauschek D, Iwata H, Jiang MY, Kaidar-Person O, Lee HB, MacKenzie M, Meyn A, Poortmans P, Poulakaki F, Richardson AL, Sepulveda KA, Spillane AJ, Thompson AM, Werutsky G, Wittmann P, Wright JL, Zdenkowski N, Cowan K, McIntosh SA, PRECEDENT Study Grou (2025). A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials. NPJ breast cancer, 11(1), 116. (Read full publication)

    Review

    1. Poppe MM, Agarwal J (2017). Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs. Journal of clinical oncology, 35(22), 2467-2470. (Read full publication)
    2. Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili (2021). Acute lymphoblastic leukemia. Pediatric blood & cancer, 68 Suppl 2, e28371. (Read full publication)
    3. Aridgides P, Janssens GO, Braunstein S, Campbell S, Poppe M, Murphy E, MacDonald S, Ladra M, Alapetite C, Haas-Kogan (2021). Gliomas, germ cell tumors, and craniopharyngioma. Pediatric blood & cancer, 68 Suppl 2, e28401. (Read full publication)

    Book Chapter

    1. Poppe MM, Blodgett T (2012). Kidney.
    2. Poppe MM, Gaffney D (2012). Adrenal Gland.
    3. Poppe MM, Shah, C, Khan, (2016). Hypofractionated Regional Nodal Irradiation for Breast Cancer. 441-466.
    4. Poppe MM, Jalali R, Murphy (2018). Pediatric Glioma. 171-202.

    Letter

    1. Meyer JE, Dilling TJ, Amdur RJ, Strasser JF, Tendulkar R, Lee WR, Jani AB, Elshaikh M, Poppe MM, Takita C, Currey A, Cheng SK, Jagsi R, Kuo JV, Chen AM, Dragun AE, Bradley K, Beriwal S, Smith RP, Chen RC, Rosenzweig K, Kim S, Mehta (2016). In regard to Wu and Vapiwala et al. International journal of radiation oncology, biology, physics, 94(4), 858-9. (Read full publication)
    2. Meyer JE, Dilling TJ, Amdur RJ, Strasser JF, Tendulkar R, Lee WR, Jani AB, Elshaikh M, Poppe MM, Takita C, Currey A, Cheng SK, Jagsi R, Kuo JV, Chen AM, Dragun AE, Bradley K, Beriwal S, Smith RP, Chen RC, Rosenzweig K, Kim S, Mehta (2016). In regard to Wu and Vapiwala et al., Taking “the Game” Out of The Match: A Simple Proposal. International journal of radiation oncology, biology, physics, 94(5), 858-9.
    3. Poppe MM, Khan A (2021). In Reply to Dyer et al. International journal of radiation oncology, biology, physics, 109(1), 301-302. (Read full publication)

    Abstract

    1. Bagshaw H, Poppe MM, Hunter (2016). Recurrent Medulloblastoma and Radiotherapy. International journal of radiation oncology, biology, physics, 96(S2), 553.

  • News & Podcasts

    Huntsman Cancer Institute News